Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Impact of epidermal growth factor receptor inhibitor in non-small cell lung cancer on progression-free an overall survival: a meta-analysis Journal:Journal of the National Cancer Institute | 2013 | 68 | ||
Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC) Proceeding/Conference:Journal of Clinical Oncology | 2016 | |||
2018 | 60 |